Latest News


Nektar closes sale of specific pulmonary delivery assets to Novartis for $115 mn

Pharmabiz.com (India) | 20 minutes ago

Nektar Therapeutics has successfully closed the divestiture of specific Nektar pulmonary delivery assets, technology, and intellectual property to Novartis for $115 million in cash. The transaction was completed on December 31, 2008.... (more)


Scientist at Work - Rob Holman - So Much to Learn About the Oceans From Sand - Biography - NYTimes.com

New York Times, The | 22 minutes ago

CORVALLIS, Ore. As a young geophysicist in the 1980s, Rob Holman attended a conference in San Francisco that included a field trip to a beach. Dr. Holman, who grew up inland, in Ottawa, stared at the ocean, assessing the strengths and vectors of the waves and currents. But when he looked around, everyone else was studying the sand. He realized, he recalled, that sand is not the same everywhere. So he started collecting it. I collected a few samples and put them in jars, he said. Then...... (more)


CRIME REPORT: Cars pounded by rocks hurled from bridge over Paul Barret Parkway : Local News : Memphis Commercial Appeal

Commercial Appeal (Memphis, Tenn.), The | 2 hours 22 minutes ago

Three vehicles, including a patrol car, have been pounded by rock or concrete chunks hurled from the Donnell Road bridge over Paul Barret Parkway in North Shelby County.... (more)


Cigna to cut about 1,100 jobs, 4 pct of work force

Boston Globe, The | 2 hours 26 minutes ago

INDIANAPOLIS—Managed care provider Cigna Corp. said Monday the slumping economy has forced it to cut roughly 1,100 jobs, as it deals with employer customers who also are making cuts and reducing the number of people covered by insurance.... (more)


Endo to buy Indevus for $370 million upfront

Boston Globe, The | 2 hours 26 minutes ago

NEW YORK—Endo Pharmaceutical Holdings Inc. said Monday it will buy Indevus Pharmaceuticals Inc. for $370 million upfront, or $4.50 per share, acquiring Invedus' urology and hormone drug candidates in the process.... (more)


Investor's Business Daily: Biotech Firm Sticks To Its Work While Drug Giant Roche Circles

Investor's Business Daily | 3 hours 14 minutes ago

Posted 1/5/2009 Last summer, Genentech (DNA) rejected Swiss drug maker Roche Holding's $43.7 billion offer to buy the company. The $89-a-share bid was too low, the biotech giant's board said, but it kept the door open for a higher bid.... (more)


Biogen shares fall on JP Morgan downgrade - Forbes.com

Forbes | 5 hours 1 minute ago

Shares of Biogen Idec Inc. fell Monday after JP Morgan cut its rating on the stock, saying the multiple sclerosis drug Tysabri could continue facing challenges in 2009 while the company lacks any catalysts to drive new revenue.... (more)


Takeover of Alpharma Will Give Actavis Rights to Kadian

FDAnews | 5 hours 2 minutes ago

King Pharmaceuticals’ acquisition of Alpharma, completed last week, will give the merged company an expanded pain drug portfolio that will include the muscle relaxant Skelaxin, the Flector patch and Embeda.... (more)


Insurer Cigna to cut about 1,100 jobs, or 4 percent of its work force, in response to economy

Hartford Courant (Conn.), The | 5 hours 7 minutes ago

INDIANAPOLIS (AP) — Managed care provider Cigna Corp. said Monday the slumping economy has forced it to cut roughly 1,100 jobs, as it deals with employer customers who also are making cuts and reducing the number of people covered by insurance.... (more)


Endo To Buy Indevus - Forbes.com

CNS Magazine | 5 hours 8 minutes ago

Endo Pharmaceuticals, best known for the pain drugs Percocet and Lidoderm, plans to purchase Indevus Pharmaceuticals, a maker of treatments for urinary incontinence for $370 million in cash now and, in a twist, $267 million more if it hits certain regulatory and sales milestones, the companies said.... (more)




 1  2  3  4  5  6  7  8   Next >

105 Stories  |   RSS Feed



Sign up for AANP SmartBrief



Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more

Latest Blog Postsview more


Companies in the news